TC BioPharm to Present at the Sequire Investor Summit in Puerto Rico
EDINBURGH, Scotland, April 19, 2023 (GLOBE NEWSWIRE) — TC BioPharm (Holdings) PLC (“TC BioPharm” or…
Month: April 2023
TC BioPharm to Present at the Sequire Investor Summit in Puerto Rico
EDINBURGH, Scotland, April 19, 2023 (GLOBE NEWSWIRE) — TC BioPharm (Holdings) PLC (“TC BioPharm” or…
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
Nes-Ziona, Israel, April 19, 2023 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
Nes-Ziona, Israel, April 19, 2023 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
electroCore to Announce First Quarter Financial Results on Wednesday, May 3
ROCKAWAY, N.J., April 19, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
electroCore to Announce First Quarter Financial Results on Wednesday, May 3
ROCKAWAY, N.J., April 19, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
Oncotelic Therapeutics and Vectara Announce Strategic Partnership to Transform Pharmaceutical Research with Large Language Model Technology
The companies are executing on the shared vision of utilizing AI for effective knowledge management…
Oncotelic Therapeutics and Vectara Announce Strategic Partnership to Transform Pharmaceutical Research with Large Language Model Technology
The companies are executing on the shared vision of utilizing AI for effective knowledge management…
Publication Validates geneType Prostate Cancer Risk Test
MELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
Publication Validates geneType Prostate Cancer Risk Test
MELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
Cognition Therapeutics to Present Analysis Showing Impact of CT1812 on Pathways Implicated in Dry Age-related Macular Degeneration at ARVO 2023
NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX) will be…
Cognition Therapeutics to Present Analysis Showing Impact of CT1812 on Pathways Implicated in Dry Age-related Macular Degeneration at ARVO 2023
NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX) will be…
QI Graduates from NEC X’s Venture Studio Program With AI-Generated Personalized Marketing Content Platform
QI is the only AI-powered content creator that offers end-to-end personalization, saving time by 65%…
QI Graduates from NEC X’s Venture Studio Program With AI-Generated Personalized Marketing Content Platform
QI is the only AI-powered content creator that offers end-to-end personalization, saving time by 65%…
Verizon continues to upgrade San Diego’s network
Recent upgrades lead to testing results that show Verizon customers have an excellent network experience…
Verizon continues to upgrade San Diego’s network
Recent upgrades lead to testing results that show Verizon customers have an excellent network experience…
Verizon continues to upgrade Madison’s best network
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
Verizon continues to upgrade Madison’s best network
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
LaunchDarkly Announces New Partner Track to Expand Its Experimentation Footprint
OAKLAND, Calif., April 19, 2023 (GLOBE NEWSWIRE) — LaunchDarkly, the leader in feature management, today…
LaunchDarkly Announces New Partner Track to Expand Its Experimentation Footprint
OAKLAND, Calif., April 19, 2023 (GLOBE NEWSWIRE) — LaunchDarkly, the leader in feature management, today…